Who makes Glandosane?

Glandosane is developed by Charite University, Berlin, Germany.

Last reviewed 2026-04-19 · How we verify

Glandosane

Charite University, Berlin, Germany · discontinued Small molecule

At a glance

Generic name	Glandosane
Also known as	Glandosane, Cell Pharm, Germany
Sponsor	Charite University, Berlin, Germany
Modality	Small molecule
Therapeutic area	Other
Phase	discontinued

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Vergleichende, Randomisierte, Kontrollierte Und Doppelblinde In-situ-Studie Zur Wirkung Von Speichelersatzmitteln Auf Schmelz Und Dentin (Phase 2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Glandosane CI brief — competitive landscape report
Glandosane updates RSS · CI watch RSS
Charite University, Berlin, Germany portfolio CI